Literature DB >> 15711055

Neural precursor cells and their role in neuro-oncology.

Khalid Shah1, Gary Hsich, Xandra O Breakefield.   

Abstract

Neural precursor cells (NPCs) provide a new mode for delivery of genes and proteins to brain tumors. These cells exist both in the developing and the adult nervous systems of all mammalian organisms. They have the ability to self-renew, migrate to diseased areas of the brain and differentiate into neurons, astrocytes and oligodendrocytes. The migratory ability of NPCs and their capacity to differentiate into all neural phenotypes provides a powerful tool for the treatment of both diffuse and localized neurological disorders. NPCs have been used in transplantation to replace damaged cells and in cancer therapy to provide therapeutic proteins and vectors to eliminate malignant cells in the brain. This review focuses on the characteristics of NPCs and their experimental use in the therapy for brain tumors. Examples are provided of monitoring migration of NPCs by bioluminescence imaging in living animals and of using them to deliver the apoptotic protein, TRAIL, to kill tumor cells. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15711055     DOI: 10.1159/000082132

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  9 in total

Review 1.  Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?

Authors:  B J Schaller; M Modo; M Buchfelder
Journal:  Mol Imaging Biol       Date:  2007 Mar-Apr       Impact factor: 3.488

Review 2.  Cancer stem cells in the mammalian central nervous system.

Authors:  G J Pilkington
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

Review 3.  Stem cell transplantation in brain tumors: a new field for molecular imaging?

Authors:  Nora Sandu; Bernhard Schaller
Journal:  Mol Med       Date:  2010-06-30       Impact factor: 6.354

Review 4.  Stem cells in mammary development and carcinogenesis: implications for prevention and treatment.

Authors:  Gabriela Dontu; Suling Liu; Max S Wicha
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

5.  A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy.

Authors:  Shawn D Hingtgen; Randa Kasmieh; Jeroen van de Water; Ralph Weissleder; Khalid Shah
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

6.  Targeting breast to brain metastatic tumours with death receptor ligand expressing therapeutic stem cells.

Authors:  Tugba Bagci-Onder; Wanlu Du; Jose-Luiz Figueiredo; Jordi Martinez-Quintanilla; Khalid Shah
Journal:  Brain       Date:  2015-04-23       Impact factor: 13.501

Review 7.  Stem cell-based therapies for tumors in the brain: are we there yet?

Authors:  Khalid Shah
Journal:  Neuro Oncol       Date:  2016-06-09       Impact factor: 12.300

8.  Molecular imaging of stem cell therapy in brain tumors: a step towards personalized medicine.

Authors:  Nora Sandu; Bernhard Schaller
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

Review 9.  Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?

Authors:  D Widera; A Kaus; C Kaltschmidt; B Kaltschmidt
Journal:  J Cell Mol Med       Date:  2007-12-20       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.